While current reports clearly indicate that B1a and B1b cells serve as the atheroprotective populations via their production of sIgM, identification of BCR-dependent signals, particularly the effects of tonic signaling, and the biological context that could lead to B1 cell expansion and activation in atherosclerosis, should be an important future research goal for the field. This evidence concerns the gene BCR and atherosclerosis.